IMANX Mutual Fund

IMANX Mutual Fund

NAV$23.34
See how much of IMANX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jun 30, 2026

Net Assets
$270M
Expense Ratio
1.00%
Dividend Yield (Current)
0.10%
Holdings
124
Inception Date
Jun 30, 2000
Fund Family
Allied Asset Advisors
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+18.14%
1 Year+28.97%
3 Year+20.56%
5 Year+13.66%
10 Year+18.17%

Asset Allocation

Stocks: 100.00%
See how much of IMANX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
AAPLApple, Inc7.34%
NVDANvidia Corp6.04%
TSM:TWTaiwan Semiconductor - Adr5.71%
GOOGLAlphabet Inc,class A5.33%
MSFTMicrosoft Corp4.33%
Top 10 Concentration: 47.48%Report Date: Jun 30, 2026
Download all 124 holdings for IMANX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.10%
Frequency
Annually
Latest Distribution
$3.01
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

IMANX Mutual Fund Overview

IMANX Mutual Fund (Iman Fund Class K) is managed by Allied Asset Advisors with $269.9M in net assets. IMANX expense ratio is 1.00%, holding 124 positions across sectors including Information Technology, Communication Services, Health Care. Inception date: 2000-06-30.

IMANX performance shows a YTD return of 18.14%. The 1-year return is 28.97% and the 5-year return is 13.66%. IMANX dividend yield stands at 0.10%, paid annually.

IMANX top holdings include Apple, Inc (7.3%), Nvidia Corp (6.0%), Taiwan Semiconductor - Adr (5.7%), Alphabet Inc,class A (5.3%), Microsoft Corp (4.3%). Go to all IMANX holdings, IMANX sectors, or IMANX dividends.

IMANX can be compared against other funds. Use IMANX overlap to find shared positions, or IMANX vs another fund for a side-by-side view. IMANX alternatives are available via the screener, along with tax-loss harvesting opportunities.